LeviFLucchiniFNegriELa VecchiaC: Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart2002; 88:119–24.
2.
SartiCRastenyteDCepaitisZTuomilehtoJ: International trends in mortality from stroke, 1968 to 1994. Stroke2000; 31:1588–601.
3.
TruelsenTMahonenMTolonenH. Trends in stroke and coronary heart disease in the WHO MONICA project. Stroke2003; 34:1346–52.
4.
BhattDLStegPGOlimanF. International prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA2006; 295:180–9.
5.
EzzatiMHoornSVRodgersALopezADMathersCDMurrayCJ: Estimates of potential health gains from reducing multiple major risk factors. Lancet2003; 362:271–80.
6.
Heart Protection Study Collaborative Group: MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized-placebo-controlled trial. Lancet2002; 360:7–22.
7.
MurrayCJLauerJAHutusbessyRC. Effectiveness and costs on intervention to lower systolic blood pressure and cholestero: a global and regional analysis on reduction of cardiovascular risk. Lancet2003;361:717–25.
RodriguezTMalvezziMChatenoudL. Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970–2000. Heart2006; 92:453–60.
10.
RothwellPMCoullAJGilesMF. Change in stroke incidence, mortality, case-fatality, severity and risk factors in Oxfordshire, UK, from 1981 to 2004 (Oxford vascular study). Lancet2004; 363:1925–33.
11.
World Health Organization: The World Health Report 2003: Shaping the Future. Geneva: World Health Organization.
12.
KazuiSKimuraKMinematsuKYamaguchiT: Multicenter survey on clinical features and regional variations in acute brain infarction. Clin Neurol (in Japanese)2002; 42:736–44.
13.
Algra A, for the ESPRIT Study Group: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomized controlled trial. Lancet2006; 367:1665–73.
14.
BonitaRMendisSTruelsenTBogousslavskyJTooleJYatsuF: The global stroke initiative. Lancet2004; 3:391–3.
15.
Antithrombotic trialists' Collaboration: Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients (REACH). BMJ2002; 324:71–86.